Serum Epstein-Barr virus (EBV) viral load can be a complementary sensitive test in primary Epstein-Barr virus infection

Mario Berth et al. J Clin Virol. 2011 Feb.

. 2011 Feb;50(2):184-5.

doi: 10.1016/j.jcv.2010.11.002. Epub 2010 Nov 26.

No abstract available

Similar articles

Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ, Smits PH, Verkuijlen SA, Rockx DA, van Gorp EC, Mulder JW, Middeldorp JM. Stevens SJ, et al. AIDS. 2007 Oct 18;21(16):2141-9. doi: 10.1097/QAD.0b013e3282eeeba0. AIDS. 2007. PMID: 18090040
Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.
Bauer CC, Aberle SW, Popow-Kraupp T, Kapitan M, Hofmann H, Puchhammer-Stöckl E. Bauer CC, et al. J Med Virol. 2005 Jan;75(1):54-8. doi: 10.1002/jmv.20237. J Med Virol. 2005. PMID: 15543583
[Diagnosis of EBV infection].
Kikuta H. Kikuta H. Nihon Rinsho. 2006 Mar;64 Suppl 3:617-20. Nihon Rinsho. 2006. PMID: 16615546 Review. Japanese. No abstract available.
Epstein-Barr virus in pediatric patients after renal transplantation.
Schwab M, Böswald M, Korn K, Ruder H. Schwab M, et al. Clin Nephrol. 2000 Feb;53(2):132-9. Clin Nephrol. 2000. PMID: 10711415
Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH, Wolf H, Minarovits J. Niller HH, et al. Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Autoimmunity. 2008. PMID: 18432410 Review.

Clinical and Pathological Features of Hydroa Vacciniforme-Like Lymphoproliferative Disorder Along with Risk Factors Indicating Poor Prognosis.
Chang L, Zhang C, Lu J, Shen J, Hamal K, Liu D. Chang L, et al. Infect Drug Resist. 2023 Mar 16;16:1545-1559. doi: 10.2147/IDR.S402040. eCollection 2023. Infect Drug Resist. 2023. PMID: 36960391 Free PMC article.